Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
18.14
-0.10 (-0.55%)
May 29, 2026, 4:00 PM EDT - Market closed
Fulgent Genetics Employees
Fulgent Genetics had 1,315 employees as of December 31, 2025. The number of employees increased by 2 or 0.15% compared to the previous year.
Employees
1,315
Change (1Y)
2
Growth (1Y)
0.15%
Revenue / Employee
$243,609
Profits / Employee
-$56,129
Market Cap
515.19M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,315 | 2 | 0.15% |
| Dec 31, 2024 | 1,313 | 129 | 10.90% |
| Dec 31, 2023 | 1,184 | 172 | 17.00% |
| Dec 31, 2022 | 1,012 | 367 | 56.90% |
| Dec 31, 2021 | 645 | 165 | 34.38% |
| Jun 30, 2021 | 626 | 153 | 32.35% |
| Mar 31, 2021 | 700 | 561 | 403.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| GeneDx Holdings | 1,300 |
| Castle Biosciences | 942 |
| CareDx | 765 |
| FONAR | 535 |
| Biodesix | 334 |
FLGT News
- 8 days ago - Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm - GlobeNewsWire
- 9 days ago - Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting - Business Wire
- 10 days ago - Fulgent Genetics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 25 days ago - Fulgent Genetics price target lowered to $15 from $30 at Piper Sandler - TheFly
- 26 days ago - Foundation Medicine to Launch FoundationOne®PGx, a Pharmacogenetic Offering, Through Expanded Partnership with Fulgent Genetics - Business Wire
- 4 weeks ago - Fulgent Genetics Earnings Call Transcript: Q1 2026 - Transcripts
- 4 weeks ago - Fulgent Genetics Earnings release: Q1 2026 - Filings
- 4 weeks ago - Fulgent Genetics Slides: Q1 2026 - Filings